All Articles, News & Resources

Search, filter, and explore articles, updates, and tools that support better oversight.

Scroll

All Articles, News & Resources

Search, filter, and explore articles, updates, and tools that support better oversight.

Cyntegrity logo – Risk-Based Quality Management Solutions

Trending Now: Most-Read by Clinical Teams

Trending Now: Most-Read by Clinical Teams

Risk-based quality management in 2026

Risk-based quality management in 2026: how ICH E6(R3) defines RBQM, where practice diverges, and what

5 Key Questions to Ask When Evaluating RBQM Platforms (ICH E6(R3)-Ready)

Learn the 5 essential evaluation questions when comparing RBQM systems. Ensure transparency, traceability, collaboration, and

ICH E6(R3) Sponsor Responsibilities: What’s New and What It Means for You

Understand sponsor responsibilities under ICH E6(R3) and how to meet modern GCP expectations using risk-based,

Quality Tolerance Limits (QTLs) in Clinical Trials

Quality tolerance limits (QTLs) define when trial performance risks safety or data integrity. This guide

From spreadsheets to Digital RACT | ICH E6(R3) compliance

Learn why spreadsheet-based RACT falls short of ICH E6(R3) and how Digital RACT in the MyRBQM Portal delivers traceable, inspection-ready risk governance....

From EMA Findings to ICH E6(R3): QbD and RBQM in Practice

How EMA inspection findings translate into ICH E6(R3) expectations, and why Quality by Design and RBQM must operate together in clinical trials....

Risk-based quality management in 2026

Risk-based quality management in 2026: how ICH E6(R3) defines RBQM, where practice diverges, and what regulators now expect in clinical trials....
Diagram illustrating the FDA Total Product Lifecycle (TPLC) management approach for AI and machine learning devices, showing a continuous cycle of design, validation, submission, monitoring, and update.

FDA AI Guidance 2025 Interactive Visualizer

Explore how FDA’s 2025 AI guidance shapes lifecycle oversight for AI-enabled medical software through interactive regulatory scenarios....

All Articles News & Resources

These pages are meant to:
Attract talent aligned with your mission and additionally mindset.
Show that Cyntegrity is a company people want to work with — especially and work for.
but, Provide assurance to enterprise clients that you align with modern values (ESG, ethics, diversity).

INDUSTRY SOLUTIONS page is focused on regulatory assurance, and especially its goal is to build trust. And remove perceived risk from decision-makers like Project, Program, Operations leads, QA leads, regulatory officers, clinical compliance managers, and procurement teams.

Trusted Compliance page is focused on regulatory assurance, and additionally its goal is to build trust and remove perceived risk from decision-makers. like QA leads, regulatory officers, clinical compliance managers, and procurement teams, but.

Key Capabilities pages are meant to tease our technical and especially operational capabilities, but not overwhelm. but, They should:
Show how it works, Prove interoperability, Make it easy to request technical info (not deliver it all upfront)

Connect & Deploy – These are deeper technical capabilities. Visitors here are:
Clinical data leads.
IT/integration specialists.
Ops leaders trying to understand if your platform plugs into theirs.
These pages also must communicate technical readiness but still follow your “teaser-first. CTA-driven” rule — no docs, SDKs, or especially schemas upfront.

Compliance Snapshot pages are all about building trust and especially accelerating vendor approval. Their job is to reassure IT security leads, QA managers. And procurement that Cyntegrity is fully compliant, auditable, and secure especially.
These are not product pages — they are trust assets. Also They should be simple, scannable, and downloadable especially.
These are not sales pages — also, they are trust accelerators for decision-makers who ask.
“Is this vendor secure, validated, and certified?”

All Articles News & Resources

Discover Expert Interviews & Podcasts on Clinical Innovation

Explore short interviews and podcast episodes with industry experts discussing RBQM, Clinical Operations, Data Science, and the future of clinical trials.

New episodes added regularly